FORT LAUDERDALE, Fla., October 28, 2020 / PRNewswire / – Omega-3s are known in the health and wellness industries for a variety of health benefits. Omega-3 fatty acids are most commonly found in fish oil, but can also be found in lower doses from plant sources. Omega-3 fatty acids have always been one of the best-selling health supplement products on the market as nutritional supplements are a more convenient shipping method.
Health and wellness brand Optimega has set itself the goal of developing an omega-3 supplement with a higher bioavailability rate than the competition, in an easy-to-drink, liquid shot instead of a capsule. Available in fruit flavors, Optimega OmegaShots are a best-selling product among people who have difficulty taking pills but still want the benefits of omega-3 supplements.
One such benefit of taking a healthy dose of omega-3 fish oils could be lowering levels of triglycerides in the body. A recent statement from the American Heart Association said that in people with exceptionally high levels of triglycerides, taking a dose much higher than the average dose of omega-3 fish oil could help lower those levels by as much as 20 to 30 percent.
Unlike many prescription drugs used to lower triglycerides, omega-3 fish oils, obtained either through food or supplements, do not pose a risk of adverse drug interactions. This is especially good news for older adults looking for natural, holistic, and effective wellness options.
OmegaShots come in a variety of flavors, including a daily vitamin formula, an older adult product, a prenatal solution, and an active body formula. By adapting their formulas, Optimega was able to cater to the specific needs of its customer base.
During 2020, Optimega expanded its online availability to meet e-commerce demand as more Americans purchase their supplements from home. Currently, OmegaShots are sold through most of the major online retailers, including Amazon.com. However, the company will expand its online and in-store availability in the coming year.
Please send inquiries to: